These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18525185)

  • 41. Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge.
    Poon RT
    Hepatology; 2011 Sep; 54(3):757-9. PubMed ID: 21793027
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention of intrahepatic hepatocarcinoma recurrence in patients with viral cirrhosis: two potential options.
    Tabone M; Pellicano R
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):47-52. PubMed ID: 16554706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 44. Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.
    Chong CC; Lai PB
    Br J Surg; 2013 May; 100(6):724-5. PubMed ID: 23475744
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibitory effects of acyclic retinoid (polyprenoic acid) and its hydroxy derivative on cell growth and on secretion of alpha-fetoprotein in human hepatoma-derived cell line (PLC/PRF/5).
    Fukutomi Y; Omori M; Muto Y; Ninomiya M; Okuno M; Moriwaki H
    Jpn J Cancer Res; 1990 Dec; 81(12):1281-5. PubMed ID: 1703522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
    Clavien PA
    Ann Surg; 2007 Jun; 245(6):843-5. PubMed ID: 17522507
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated.
    Hann HW; Bergin D; Coben R; DiMarino AJ
    Int J Cancer; 2011 Feb; 128(3):739-42. PubMed ID: 20473872
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comprehensive prevention and treatment of recurrence for hepatocellular carcinoma after hepatectomy].
    Xia Y; Shen F
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):326-8. PubMed ID: 24052959
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment.
    Schlitt HJ; Schnitzbauer AA
    Liver Transpl; 2011 Nov; 17 Suppl 3():S10-2. PubMed ID: 21850696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
    Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
    Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.
    Nakamura N; Shidoji Y; Yamada Y; Hatakeyama H; Moriwaki H; Muto Y
    Biochem Biophys Res Commun; 1995 Feb; 207(1):382-8. PubMed ID: 7857292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cell-based immunotherapy for hepatocellular carcinoma.
    Onji M; Akbar F; Horiike N
    J Gastroenterol; 2001 Nov; 36(11):794-7. PubMed ID: 11757756
    [No Abstract]   [Full Text] [Related]  

  • 53. Altered retinoic acid receptors.
    de Thé H
    FASEB J; 1996 Jul; 10(9):955-60. PubMed ID: 8801177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maintenance interferon for chronic hepatitis C: more issues than answers?
    Everson GT
    Hepatology; 2000 Aug; 32(2):436-8. PubMed ID: 10915756
    [No Abstract]   [Full Text] [Related]  

  • 55. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation.
    Wang ZY; Geng L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):145-9. PubMed ID: 25865686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of retinoid receptors in inhibiting proliferation and inducing apoptosis of human melanoma cell line A375.
    Niu XW; Peng ZH; Feng J; Ma HQ; Liu C; Yuan JY
    Chin Med J (Engl); 2005 Sep; 118(17):1482-6. PubMed ID: 16157052
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical application of vitamin K for hepatocellular carcinoma].
    Mizuta T; Ozaki I
    Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of liver cancer.
    Guyton KZ; Kensler TW
    Curr Oncol Rep; 2002 Nov; 4(6):464-70. PubMed ID: 12354357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
    Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.